Principles[ edit ] D-dimer formation. Shown are fibrinogen , with its one E domain and two D domains, acted upon in cascade, by the following enzymes : Thrombin , to create a mesh of fibrin protofibrils; Factor XIII to crosslink the fibrin mesh linking protofibril D domains , the scaffold for clot formation; Plasmin , whose action in fibrinolysis produces fibrin degradation products FDPs , the smallest of which are D-dimers, protein fragments with one E and two crosslinked D domains from an original fibrinogen. Both pathways lead to the generation of thrombin , an enzyme that turns the soluble blood protein fibrinogen into fibrin, which aggregates into proteofibrils. Another thrombin-generated enzyme, factor XIII , then crosslinks the fibrin proteofibrils at the D fragment site, leading to the formation of an insoluble gel which serves as a scaffold for blood clot formation. The resultant fragments, "high molecular weight polymers", are digested several times more by plasmin to lead to intermediate and then to small polymers fibrin degradation products or FDPs. The cross-link between two D fragments remains intact, however, and these are exposed on the surface when the fibrin fragments are sufficiently digested.
|Published (Last):||3 May 2018|
|PDF File Size:||19.71 Mb|
|ePub File Size:||14.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
Adam, N. Key, C. Greenberg, D-dimer antigen: current concepts and future prospects , in Blood, vol. URL consultato il 2 novembre Suzuki, A. Distante; K. Eagle, Biomarker-assisted diagnosis of acute aortic dissection: how far we have come and what to expect. Ranasinghe, RS. Bonser, Biomarkers in acute aortic dissection and other aortic syndromes. Wells, DR. Anderson; M. Rodger; JS. Ginsberg; C. Kearon; M. Gent; AG. Turpie; J. Bormanis; J. Weitz; M. Chamberlain; D. Bowie, Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.
Wells, J. Hirsh; DR. Anderson; AW. Lensing; G. Foster; C. Kearon; J. Weitz; R. Cogo; P. Prandoni, Accuracy of clinical assessment of deep-vein thrombosis.
Rodger; M. Forgie; C. Dreyer; G. Kovacs; M. Mitchell; B. Lewandowski; MJ. Kovacs, Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. Rathbun, TL.
Whitsett; SK. Vesely; GE. Raskob, Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Fesmire, MD. Brown; JA. Espinosa; RD. Shih; SM. Silvers; SJ. Wolf; WW. Decker; WW. Decker; FM. Fesmire; MD. Brown; DB. Diercks, Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected pulmonary embolism.
Torbicki, A. Perrier; S. Konstantinides; G. Agnelli; N. Pruszczyk; F. Bengel; AJ. Brady; D. Ferreira; U. Janssens; W. Qaseem, V. Snow; P. Barry; ER. Hornbake; JE. Rodnick; T. Tobolic; B. Ireland; J. Segal; E. Bass; KB. Weiss; L. Green, Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.
Schrecengost, RD. LeGallo; JC. Boyd; KG. Moons; SL. Gonias; CE. Rose; DE. Bruns, Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimer testing for the evaluation of suspected pulmonary embolism.
Mos; R. Douma; P. Erkens; M. Durian; T. Nizet; A. Hofstee; H. Ullmann; H. Douma, G. Righini; PW. Kamphuisen; A. Perrier; MJ. Kruip; H. Bounameaux; HR. Roy, Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts.
Coagulación, Dímero D y COVID-19
Prueba del dímero D
Dímero-D positivo o elevado ¿qué significa para el diagnóstico de tromboembolismo pulmonar?